Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Koenig

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trialsJuan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
Infection|May 13, 2021
COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, AustriaErich Pawelka, Mario Karolyi, Theresa Mader, et al.
Pharmaceutical Statistics|March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Communications Medicine|July 16, 2024
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitisElena Sena, Frank Tacke, Quentin M Anstee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancerAnna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Wiener Klinische Wochenschrift|October 27, 2022
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysisMario Karolyi, Lukas Kaltenegger, Erich Pawelka, et al.
Kidney International Reports|February 12, 2024
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial DesignLisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trialsJuan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
Infection|May 13, 2021
COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, AustriaErich Pawelka, Mario Karolyi, Theresa Mader, et al.
Pharmaceutical Statistics|March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Communications Medicine|July 16, 2024
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitisElena Sena, Frank Tacke, Quentin M Anstee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancerAnna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Wiener Klinische Wochenschrift|October 27, 2022
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysisMario Karolyi, Lukas Kaltenegger, Erich Pawelka, et al.
Kidney International Reports|February 12, 2024
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial DesignLisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, et al.
Pageof 7